Subscribe
Menu
Login
Search
Login
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
May 2022, Issue 2
Preview This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2022
Preview This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
Multimedia
Crossword Puzzles
Infographics
Science Snapshot
Videos
Webinars
Research Resources
Podcasts
Events
Infographics
eBooks
Videos
The Scientist University
Research Products Blog
Articles
Subscribe
FDA Limits Use of J&J Vaccine, Citing Safety Concerns
US adults are now only eligible for the vaccine under certain circumstances.
ABOVE: © iStock.com,
Grandbrothers
FDA Limits Use of J&J Vaccine, Citing Safety Concerns
FDA Limits Use of J&J Vaccine, Citing Safety Concerns
US adults are now only eligible for the vaccine under certain circumstances.
US adults are now only eligible for the vaccine under certain circumstances.
ABOVE: © iStock.com,
Grandbrothers
Home
Subjects
adenovirus
adenovirus
Mysterious Hepatitis Cases Reported in Young Children
Natalia Mesa | Apr 18, 2022
Officials have ruled out known hepatitis viruses as the cause of a rash of illnesses in Europe and the US.
Scientists Voice Concerns over Russian COVID-19 Vaccine Study
Amanda Heidt | Sep 11, 2020
Almost 40 scientists have signed an open letter, citing odd patterns in the data and a lack of transparency after authors withheld the full data.
Improving Cancer Immunotherapy with Anti-Cancer Adenoviruses
The Scientist Creative Services Team, IsoPlexis | Jun 25, 2021
Researchers use a mesenchymal stromal cell-based vector to deliver multiple viruses simultaneously to improve CAR-T cell anti-tumor activity.
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
Chimp Viruses for Human Vaccines
Ruth Williams | Jan 4, 2012
An adenovirus isolated from chimpanzee feces proves more effective than human adenoviruses as a vaccine vector for hepatitis C.
LabTalk Podcast - A Modern Trojan Horse: Delivering Combination Immunotherapies to Solid Tumors
The Scientist Creative Services Team, IsoPlexis | Apr 26, 2021
Katie McKenna discusses a combination CAR T and viral therapy that kills solid tumors.
Virus Jumps Between Primates
Megan Scudellari | Jul 18, 2011
In the first known case of a cross-species outbreak of an adenovirus, researchers identify a virus that infected both monkeys and humans.